IL1α Cancer Research Results
IL1α, interleukin-1 alpha: Click to Expand ⟱
| Source: |
| Type: |
The term "IL-1" is often used as an umbrella term for the interleukin-1 family, which includes multiple cytokines. The two best-known members are IL-1α and IL-1β.
L-1α: Often expressed as a precursor that is biologically active even before processing; it can be active in its intracellular form and when expressed on the cell surface.
IL-1α is typically associated with cell damage and tends to act more locally.
High IL-1α levels have been detected in a number of tumor cells and have been associated with enhanced tumor invasion and metastasis in several settings.
|
NA, Not Available: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
TNF-α↓, IL6↓, IL1α↓, P53↑, Bcl-xL↓, Bcl-2↓, BAX↑, Hif1a↓, VEGF↓, TumCCA↑, DNAdam↑, Apoptosis↑, CycB/CCNB1↓, cycA1/CCNA1↓, CDK1↓, PI3K↓, Akt↓, mTOR↓, IKKα↓, ERK↓, p‑Akt↓, p‑P70S6K↓, p‑S6↓, p‑ERK↓, p‑P90RSK↑, STAT3↓, MMP2↓, MMP9↓, TumCP↓, TumCMig↓, TumCI↓, Wnt/(β-catenin)↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis ⓘ
p‑S6↓, 1,
Cell Death ⓘ
Akt↓, 1, p‑Akt↓, 1, Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 1,
Cell Cycle & Senescence ⓘ
CDK1↓, 1, cycA1/CCNA1↓, 1, CycB/CCNB1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
ERK↓, 1, p‑ERK↓, 1, mTOR↓, 1, p‑P70S6K↓, 1, p‑P90RSK↑, 1, PI3K↓, 1, STAT3↓, 1, Wnt/(β-catenin)↓, 1,
Migration ⓘ
MMP2↓, 1, MMP9↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
IKKα↓, 1, IL1α↓, 1, IL6↓, 1, TNF-α↓, 1,
Clinical Biomarkers ⓘ
IL6↓, 1,
Total Targets: 33
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: IL1α, interleukin-1 alpha
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:0 Cells:% prod#:% Target#:977 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page